Glenmark Life Sciences Ltd files DRHP with SEBI for IPO equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Glenmark arm files IPO papers with SEBI
April 17, 2021
Plans to sell over 73 lakh shares via Offer For Sale
Glenmark Life Sciences Limited, a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, has filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offer.
The company plans to raise ₹1,160 crore with an Offer For Sale of up to 7,305,245 equity shares of ₹2 each of Glenmark Life Sciences Limited. The board of directors of Glenmark Pharmaceuticals Limitedon Friday approved the OFS.
Glenmark Pharma holds 100 per cent stake in Glenmark Life Sciences, which is primarily into manufacturing and marketing of Active Pharmaceutical Ingredients (APIs). It has a product portfolio of more than 130 APIs and a catalogue of over 270 inventions. The firm, which supplies APIs to more than 700 customers across 65 countries, also develops 10-12 new products every year. Glenmark Life Sciences has manufacturing operations in Gujara
Share:
New York, April 16, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Anesthetic Drugs Market Research Report by Drug Type, by Route of Administration, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 - https://www.reportlinker.com/p06063102/?utm source=GNW
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Anesthetic Drugs Market is expected to grow from USD 4,198.28 Million in 2020 to USD 5,489.67 Million by the end of 2025.
Data Bridge Market Research Adds “
Dermatology Drugs Market– Industry Trends and Forecast to 2028” new report to its research database. The report spread No of pages : 350 No of Figures: 60 No of Tables: 220 in it. This comprehensive
Dermatology Drugs Market industry research report includes a brief on these trends that can help the organizations operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market CAGR,Volume, industry share And size, demand and trend growth, key segments, and key drivers and restrains.
New Players in the market are facing tough competition from established international Players as they struggle with technological innovations, reliability and quality issues. The report will answer questions about the current market developments and the scope of competition, opportunity cost and more.
Glenmark s consolidated net profit rises by 30 05% greekherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from greekherald.com Daily Mail and Mail on Sunday newspapers.